Jefferies Defending Foghorn Therapeutics (FHTX) +10pct Drop: 'We view the recent pullback as a buying opportunity'
Tweet Send to a Friend
Jefferies analyst Amin Makarem reiterated a Buy rating and $12.00 price target on Foghorn Therapeutics (NASDAQ: FHTX).The analyst comments "FHTX ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
